The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The regulatory decision follows promising results from RIVER-81
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
Broadening access for children & patients with inhibitor-complicated hemophilia
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The filing is backed by Phase III data from the lidERA Breast Cancer study
Subscribe To Our Newsletter & Stay Updated
